SCHEMBL1256207

SCHEMBL1256207

Nc1ccc(-c2ccc(N)c(Cl)c2)cn1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.63
TSHR P16473 2/20 0.63
ALDH1A1 P00352 2/20 0.63
MAPK1 P28482 1/20 0.63
PIK3CD O00329 5/20 0.62
MAP4K4 O95819 2/20 0.55
ESR2 Q92731 1/20 0.53
CYP1A2 P05177 1/20 0.51
KCNH2 Q12809 1/20 0.51
MINK1 Q8N4C8 1/20 0.51
TNIK Q9UKE5 1/20 0.51
LTA4H P09960 1/20 0.50
MKNK1 Q9BUB5 1/20 0.44
MKNK2 Q9HBH9 1/20 0.44
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
USP2 O75604 1/20 0.43
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12349143 0.81 PIK3CD (0.56) CYP3A4PIK3CDMAP4K4CYP1A2KCNH2
SCHEMBL12492898 0.81 CYP3A4 (0.59) CYP3A4TSHRALDH1A1MAPK1PIK3CD
SCHEMBL29365311 0.81 CYP3A4 (0.94) CYP3A4TSHRALDH1A1MAPK1ESR2
SCHEMBL8872306 0.81 CYP3A4 (0.94) CYP3A4TSHRALDH1A1MAPK1ESR2
SCHEMBL49382 0.81 CYP3A4 (0.94) CYP3A4TSHRALDH1A1MAPK1ESR2
SCHEMBL23137319 0.79 CYP3A4 (0.90) CYP3A4TSHRALDH1A1MAPK1ESR2
Hydrochloric Acid SCHEMBL29368557 0.79 CYP3A4 (1.00) CYP3A4TSHRALDH1A1MAPK1ESR2
Hydrochloric Acid SCHEMBL30242948 0.79 CYP3A4 (1.00) CYP3A4TSHRALDH1A1MAPK1ESR2
Hydrochloric Acid SCHEMBL864592 0.79 CYP3A4 (1.00) CYP3A4TSHRALDH1A1MAPK1ESR2
Hydrochloric Acid SCHEMBL2571374 0.79 CYP3A4 (1.00) CYP3A4TSHRALDH1A1MAPK1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130035326-A1 BIARYL COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2013-02-07 US disclosed
EP-2467137-A1 BIARYL COMPOUNDS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2012-06-27 EP disclosed
WO-2011022473-A1 BIARYL COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2011-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130035326-A1 BIARYL COMPOUNDS AND METHODS OF USE THEREOF FLT3, CSF3R, CSF1R CYP3A4 2332/4885TSHR 2007/4885ALDH1A1 1695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.